MARATTO

article · Next research.

Dual-target nanotherapy: plant-derived alkaloid and albendazole in chitosan nanoparticles suppress hepatocellular carcinoma and Fasciola hepatica via glycolysis inhibition

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Helminth infection and control
  • Nanoparticle-Based Drug Delivery
  • Silymarin and Mushroom Poisoning

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.nexres.2026.101815

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.